HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil.

To study the prevalence of HIV and infections with related transmission patterns, we interviewed and obtained blood samples from 220 injecting drug users (IDUs), sampled by snowballing, from the city of Santos in the state of São Paulo, Brazil, where the estimated number of IDUs (10,000) comprises approximately 2% of the entire population. Seroprevalence of HIV, hepatitis B and C, syphilis, and HTLV (1 and 2) was assessed and compared with that in 197 blood donors from the same city, matched for age and gender. Risk behavior related to HIV was assessed by a standard questionnaire applied to the IDU sample. Univariate and multivariate analyses of the risk factors were performed. Seroprevalences found were 62% for HIV, 75% for HCV, 75% for HBV, 34% for syphilis, and 25% for HTLV (1 and 2) among IDUs, which compare with 0.0%, 2%, 23%, 12%, and 1% for blood donors, respectively. The risk for parenterally transmitted infections in this IDU community was higher than that for sexually transmitted infections (odds ratio for syphilis, 3.57; hepatitis B, 10.0; and hepatitis C, 100). The results of the mutivariate risk analysis showed that daily rate of ID use >5 times/day (OR = 6.73), not changing behavior to avoid AIDS (OR= 3.28), ID use >15 days/month (OR = 2.72), and ID use in the last 2 months (OR = 2.23) were the risk behaviors significantly associated with HIV infection.

[1]  T. Guthe,et al.  Treponema pallidum. A bibliographical review of the morphology, culture and survival of T. pallidum and associated organisms. , 1966, Bulletin of the World Health Organization.

[2]  J. Eberle,et al.  ANTIBODIES TO HEPATITIS C VIRUS , 1989, The Lancet.

[3]  C. M. T. Martelli,et al.  Rastreamento sorológico para doenças infecciosas em banco de sangue como indicador de morbidade populacional , 1989 .

[4]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[5]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[6]  Raymundo Machado de Azevedo Neto,et al.  Sorologia positiva para sífilis, toxoplasmose e doença de Chagas em gestantes de primeira consulta em centros de saúde de área metropolitana, Brasil , 1990 .

[7]  H. Greenberg,et al.  Antibodies to hepatitis C virus in low-risk blood donors: implications for counseling positive donors. , 1991, Gastroenterology.

[8]  C. Stornello.  Transmission of hepatitis B via human bite , 1991, The Lancet.

[9]  R. Gutierrez,et al.  Detection of antibodies to hepatitis C virus in U.S. blood donors , 1991, Journal of clinical microbiology.

[10]  J. Muller,et al.  HCV confirmatory testing of blood donors. , 1991, Lancet.

[11]  B. Vanderborght,et al.  Prevalence of Anti‐Hepatitis C Virus in the Blood Donor Population of Rio de Janeiro , 1993, Vox sanguinis.

[12]  E Massad,et al.  The basic reproduction ratio of HIV among intravenous drug users. , 1994, Mathematical biosciences.

[13]  S. Friedman,et al.  AIDS and the use of injected drugs. , 1994, Scientific American.

[14]  S. Blower,et al.  Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. , 1994, Science.

[15]  D. D. Des Jarlais,et al.  Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. , 1994, Addiction.